Inventor
Melvin L. Rueppel
Inventor
St. Louis, MO, US
Overview
Patents· 59 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds26%
C07CAcyclic or carbocyclic compounds20%
C07BGeneral methods of organic chemistry18%
B01DSeparation13%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations10%
A61KPreparations for medical, dental or toiletry purposes7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C07KPeptides1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
PatentTitleYear
7,700,658'(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity'20107,253,211'(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity'20077,122,536'(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity'20067,119,094'Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade'20067,105,559'Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade'20067,015,223'Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade'20067,015,230'Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade'20066,969,715'6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade'20056,924,313'Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity'20056,908,919'Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade'20056,870,056'Substitituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade'20056,867,217'Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade'20056,861,561'Substituted aromatic policyclic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity'20056,828,338'Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade'20046,803,388'(R)-Chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,787,570'Substituted N-cycloalkyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,765,023'Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,750,342'Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade'20046,723,752'(R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,723,753'Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,716,838'Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents'20046,710,089'Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,699,898'Substituted N,N-disubstituted non-fused heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,696,435'Substituted N,N-disubstituted fused-heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,696,472'Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,683,099'Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,683,113'(R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,677,379'Substituted N,N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,677,341'(R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,677,382'Substituted N,N-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,677,375'Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,677,380'Substituted N, N-disubstituted mercapto amino compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,677,353'Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,664,255'Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade'20036,653,316'Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade'20036,624,180'Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade'20036,586,433'Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20036,583,183'Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20036,544,974'(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activity'20036,521,607'(R)-chiral halogenated substituted N-phenoxy N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20036,482,862'Method of using substituted N-benzyl-N-phenyl aminoalcohols for inhibiting cholesteryl ester transfer protein activity'20026,479,552'Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity'20026,476,057'Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity'20026,476,075'Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity'20026,462,092'Use of substituted N, N-disubstituted reverse aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity'20026,458,952'Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade'20026,458,803'Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity'20026,458,849'use of substituted N,N-disubstituted mercapto amino compounds for inhibiting cholesteryl ester transfer protein activity'20026,458,852'Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity'20026,455,519'Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity'20026,451,830'Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity'20026,451,823'Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity'20026,448,295'Use of substituted N-fused-phenyl-N-benzyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity'20025,948,937'Method for producing N-phosphonomethylglycine and its salts'19994,454,043'Column switching procedure'19844,227,888'Method for the quantitative determination of cyanide'19804,047,926'Treatment of sugarcane with N-(perfluoroacyl)-N-phosphonomethyl glycine'19774,035,176'N-(perfluoroacyl)-N-phosphonomethyl glycine compounds, method of preparing same'19773,970,695'N-(perfluoroacyl)-N-phosphonomethyl glycine compounds, method of preparing same'1976Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1976–1999Patents assigned to MONSANTO CO (6)· patent assignee history
1976–1999Based in Kirkwood, MO, US· patent location history
2002–2006Patents assigned to PHARMACIA CORP (30)· patent assignee history
2002–2005Patents assigned to SEARLE & CO (14)· patent assignee history
2002–2010Based in St. Louis, MO, US· patent location history
2004–2010Patents assigned to PFIZER (7)· patent assignee history
2004Patents assigned to PHARMACIA CORP GLOBAL PATENT D (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PHARMACIA CORP | 30 | 2002–2006 |
| SEARLE & CO | 14 | 2002–2005 |
| PFIZER | 7 | 2004–2010 |
| MONSANTO CO | 6 | 1976–1999 |
| PHARMACIA CORP GLOBAL PATENT D | 1 | 2004 |
Locations
| Location | Patents | Span |
|---|---|---|
| St. Louis, MO, US | 53 | 2002–2010 |
| Kirkwood, MO, US | 6 | 1976–1999 |